Ivermectin, an avermectin antiparasitic drug used in humans, reduces hyperglycemia and hyperlipidemia symptoms in the diabetic mice model at submicromolar concentrations via FXR-mediated signaling10. This evidence concerns the gene NR1H4 and hyperlipidemia.